FDA approves new Alzheimer's drug to slow disease progression
The FDA has approved a groundbreaking new drug to slow the progression of Alzheimer's disease in its early stages, offering new hope for millions of Americans affected by the condition.
Beyond Mounjaro and Zepbound: 6 Other Drugs That Could Be Blockbusters for Eli Lilly
Lilly clearly has an abundance of growth drivers -- and the list includes more than Mounjaro, Zepbound, and the six drugs discussed earlier. Cancer drug Verzenio, type 2 diabetes drug Jardiance, and autoimmune disease drug Taltz are all blockbusters with strong sales momentum.
US FDA approves Eli Lilly's drug for eczema
Eli Lilly said on Friday the U.S. Food and Drug Administration approved its eczema drug for use in adults and children above 12 years old. The drug, which is an injectable medicine and branded Ebglyss,
FDA approves Lilly's treatment for eczema
"I was pissed. I was upstaged by this younger kid" - Ex-Lower Merion HS team captain recalls how Kobe Bryant replaced him 31 Make-Ahead Casseroles We’re Eating All Fall Long The Average Salary in the US vs. Canada Kurt Russell's Favorite Movie Of All Time Is A 1940s Classic The Absolute Best Hair, Makeup, and Beauty Looks at the 2024 Emmys Toyota's Most Powerful 4-Cylinder Engine From First to Worst: NFL’s Power Rankings After Week 2; Chiefs Scrape Past Bengals, Ravens Shocked by Raiders Earth's greatest mass extinction 250 million years ago shows what happens when El Niño gets out of control New solar project expected to be one of the largest in the nation: 'Can help unlock new clean energy at a rate that matches the pace and scale of demand growth' Friends actor Aisha Tyler says show’s original casting reflected attitude that ‘only white stories sold’ 91% of America's millionaires don't consider themselves 'upper-class rich' — so how does a seven-figure net worth really stack up in the US? I Just Learned What Paprika Is Really Made From, And I Need To Lie Down Matt Ryan left Peyton and Eli Manning speechless with his end-of-game logic for the Eagles and Falcons thriller
Los Angeles Times2h
FDA Approval of Kisunla Brings Change to Alzheimer’s
The FDA’s approval of Kisunla demonstrates a positive change in Alzheimer disease management. Offering illness pathology therapy and the option of treatment conclusion after reaching therapeutic goals ...
Southwest Iowa News6d
Alzheimer's Drugs May Work in Whole New Way, Study Finds
Two FDA-approved monoclonal antibody drugs are thought to curb Alzheimer's by reducing levels of protein plaques in the brain ...
Kearney Hub5d
'This is why we walk': New drug that may slow Alzheimers now offered in Kearney area
Kearney physician Dr. Bradley Rodgers will soon offer Kisunla, the first drug proven to slow the early onset of Alzheimer’s.
BioSpace9d
Late-Stage Alzheimer’s Pipeline Goes Beyond Amyloid and Tau
The next generation of Alzheimer’s therapeutics is moving away from amyloid plaques and tau tangles, offering multiple ...
Study finds Alzheimer's drugs might boost healthy protein in brain
Researchers have discovered that Alzheimer's drugs Leqembi and Kisunla boost levels of a healthy form of protein in the brain, even as they reduce its more toxic form.
Investopedia on MSN21h
9 Major Medicare Changes for 2025 and How They'll Impact Your Coverage
Wave goodbye to the Part D "donut hole" and hello to a $2,000 cap on the amount you'll pay for medications. But other changes ...
Medical News Today7d
Could simple blood tests improve Alzheimer's diagnosis in the future?
Increasingly, researchers are looking to develop blood tests that could help make Alzheimer's diagnosis faster, more accurate ...
Nature8d
Europe sidelines Alzheimer’s drug: lessons must be learnt
If the European Medicines Agency takes an overly cautious approach to selecting specialists to advise on new medicines, ...
Knowridge13d
New drug may treat memory loss in Alzheimer’s disease
In a recent breakthrough in Alzheimer’s research, scientists at Auburn University have discovered a new drug, troriluzole, ...
Psychology Today12d
Could Weight Loss Drugs Be a Psychiatric Tool?
GLP-1 agonists may improve the disease course for a host of neurological and psychiatric disorders tied to inflammation, ...
GlobalData on MSN1d
Darmiyan introduces Alzheimer’s testing platform with BrainSee test
The BrainSee test avoids traditional Alzheimer's assessments that rely on general biomarkers such as amyloid or tau.